NVIDIA Healthcare

The official handle for #NVIDIAHealthcare. Helping the scientific and developer community advance research, diagnostics, and patient care with #AI.

[NVIDIA Healthcare @NVIDIAHealth]

🧪 @UWproteindesign + 💚 NVIDIA = 👶 RFD4-Proteina

Proud parents ✨ Gifted kid

[Robin Roehm @RoehmRobin]

@NVIDIAHealth and the Institute for Protein Design, led by Nobel laureate David Baker, just released RFD4-Proteina today at GTC Berlin, an open model that designs a protein’s sequence and structure together against a target. Apheris is a launch distribution partner. We run RFD4-Proteina on your own GPUs, inside your environment, and you can fine-tune it on your own structures and assays to design VHHs, antibodies, binders and enzymes and customize it to your chemistry.

[NVIDIA Healthcare @NVIDIAHealth]

🧬@LilaSciences explores a B-cell lymphoma therapy with NVIDIA Nemotron and Agent Toolkit for planning, plus BioNeMo models for millions of virtual experiments.

Robots make and test promising candidates, using the results to guide the next round.

[Institute for Protein Design @UWproteindesign]

This is what a communal brain—a central tenet of the IPD approach—looks like in action. 🧠

We're thrilled to present RFD4-Proteina, co-developed with @NVIDIAHealth! Can't wait to see what you build: https://t.co/ezw5LPM0Bf

[UW Medicine Newsroom @uwmnewsroom]

RFD4-Proteina, co-developed by @UWproteindesign @UWMedicine & @NVIDIAHealth, debuts today at GTC Berlin. The open-source generative model will use biomolecular reasoning to find new protein solutions for medicine, sustainability, materials & biotech. https://t.co/GSy9hwvoRM

[Gabriele Corso @GabriCorso]

Today at GTC, we’re excited to announce our collaboration with Bristol Myers Squibb to bring the latest Boltz models into BMS’s drug discovery workflows. @bmsnews @boltz_bio 🚀🧵

[Sayak Paul @RisingSayak]

We just merged the first protein sequence design model RFD4-Proteina in Diffusers 🔥

I hope this pushes the state of open BioML further.

Kudos to @NVIDIAAI and Baker Lab for shipping this!

Check out the docs to know more:
https://t.co/9EkDKglFRj

[Benchling @benchling]

New from Benchling and @NVIDIAAI:
Scientists and AI agents will be able to access RFD4-Proteina for generative protein design through Benchling Model Hub.
https://t.co/MPOTfvstjf

[NVIDIA Healthcare @NVIDIAHealth]

💚 AI connects the dots so your doctor can connect with you 🩺

[NVIDIA Healthcare @NVIDIAHealth]

🔬 RFD4-Proteina joins Nemotron, Kumo, Cosmos, Alpamayo and Ising in today's NVIDIA open model release.

[NVIDIA AI @NVIDIAAI]

We’re releasing more open models to help teams across Europe build AI with their own data, on infrastructure they control.

Announced at GTC Berlin, the models help developers, researchers and enterprises build specialized AI agents, train robots, design proteins and develop quantum computers.

See what’s new: https://t.co/gXbVJfRn1b

[NVIDIA Healthcare @NVIDIAHealth]

Personalized cancer care for more patients, everywhere.

Together with @SiemensHealth, we're developing the next generation of adaptive radiotherapy to simplify workflows and expand access to care.

[NVIDIA Healthcare @NVIDIAHealth]

🚀 Run it as a NIM microservice https://t.co/hH4GA0a4Oe
💻 Get the open model on GitHub https://t.co/WFxOkWUx4Q
📣 Read the BioNeMo news from #NVIDIAGTC Berlin https://t.co/Tz9lI4y32r

[NVIDIA Healthcare @NVIDIAHealth]

🧬 Design proteins faster and send fewer, better candidates to the lab.

Introducing RFD4-Proteina, a new NVIDIA BioNeMo open model co-developed with @UWproteindesign.
▫️Fast: 13× faster generation than RFdiffusion3 at 200 residues
▫️ Smart: state-of-the-art across 12+ protein design tasks
▫️ Programmable: set your design inputs and use test-time compute on harder problems

Start with our binder-design tutorial https://t.co/fmS7miF1VD

[Deniz Kavi @kavi_deniz]

New de novo design model from Baker Lab + NVIDIA, available on Tamarind today.

We are excited to be working with @NVIDIAHealth to bring access to RFD4-Proteina on day 0.

[TrainLoop @TrainLoop_ai]

@nollahealth is pioneering access to care with AI-driven prescriptions. But critical use cases like these require superhuman performance.

Together with @nvidia and @nebius, we post-trained the new Nemotron 3.5 VL Super to SoTA on differential diagnosis.

[Terray Therapeutics @Terray_Tx]

Accurate extraction of chemical synthesis routes from scientific literature is critical to accelerating AI-native drug discovery workflows. Today, in collaboration with @nvidia , we are excited to announce state-of-the-art performance in extracting these routes using fine-tuned Nemotron 3.5 Super VL and Nemotron 3 Nano Omni. We are grateful to the team at @NVIDIAHealth for their partnership on this work and honored for our collaboration to be featured in today’s Nemotron 3.5 Super VL launch!

By embedding this capability directly into our EMMI platform, which combines proprietary hardware, scale data, chemistry-first AI, and lab-in-the-loop automation, we are enabling our agents to dynamically parse and reason over chemical documents on-the-fly, and powering a continuous data flywheel that is further expanding our access to actionable chemical space and accelerating the path to novel medicines for the patients who need them.

Read our blog: Enhanced Parsing of Chemical Reaction Diagrams https://t.co/TxqTSZSzkn
Read NVIDIA's blog: Nemotron 3.5 Super-VL Powers Specialized Agents with Multimodal Reasoning https://t.co/ZX46IaU91k

[NVIDIA Healthcare @NVIDIAHealth]

Molecules in the morning, robots in the afternoon. Two hands-on #NVIDIAGTC Berlin labs on October 22.

🧬 9:00 - Drug discovery with BioNeMo https://t.co/VqGPNIcB02
🥨 Lunch - currywurst break
🤖 13:00 - Medical robotics with Isaac for Healthcare https://t.co/Nwrc5vdOXd

[NVIDIA Healthcare @NVIDIAHealth]

What do scientists and engineers learn after 3 days of building together with AI?

✨ That agents are erasing the line between them and making it easier to build together.

Who is in for the next one?

[NVIDIA GTC @NVIDIAGTC]

The #NVIDIAGTC Berlin keynote is almost here. 🎤

NVIDIA founder and CEO Jensen Huang takes the stage at the Tempodrom on October 21 at 11 a.m. CEST. Watch the livestream from anywhere.

Add it to your calendar: https://t.co/5PLMtRXas7